Vincent Aurentz's Net Worth
$3.4 Million
Who is Vincent Aurentz?
Vincent Aurentz has an estimated net worth of $3.4 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Longboard Pharmaceuticals, Inc., and EPIRUS Biopharmaceuticals, Inc..
SEC CIK
Vincent Aurentz's CIK is 0001657494
Past Insider Trading and Trends
2021 was Vincent Aurentz's most active year for acquiring shares with 8 total transactions. Vincent Aurentz's most active month to acquire stocks was the month of December. 2022 was Vincent Aurentz's most active year for disposing of shares, totalling 10 transactions. Vincent Aurentz's most active month to dispose stocks was the month of February. 2019 saw Vincent Aurentz paying a total of $1,641,500.00 for 167,000 shares, this is the most they've acquired in one year. In 2019 Vincent Aurentz cashed out on 139,000 shares for a total of $3,296,699.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
Executive VP and CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -55.96K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +63.76% | 21.46K |
—
|
—
| 55.12K |
Jan 3
| |||
Form 4
| +24.67% | 6.66K |
—
|
—
| 33.66K |
Mar 1
| |||
Form 4
|
—
|
0
|
$49.90 | -$177,185.60 | 27K |
Scheduled
|
Feb 16
| ||
Form 4
| +200.00% | 18K |
—
|
—
| 27K |
Jan 7
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Nov 25
| |||
Form 4
|
—
|
0
|
$42.40 | -$1,130,022.50 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -100.00% | -9.00K |
$50.00 | -$450,000.00 |
0
|
Scheduled
|
Feb 5
| ||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Oct 14
| |||
Form 4
|
—
|
0
|
$37.99 | -$1,655,199.93 |
0
|
Scheduled
|
Sep 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Longboard Pharmaceuticals, Inc. (LBPH) Snapshot price: $34.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPIRUS Biopharmaceuticals, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
∞
| 2.2K |
$3.43 | $7,546.00 | 2.2K |
Dec 17
| |||
Form 4
|
∞
| 2.8K |
$3.85 | $10,780.00 | 2.8K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibikase Therapeutics, Inc. (IKT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
| No matching records found | |||||||||